Year:
2024/25
Research:
Urology
Country:
Hungary
PhD specialization:
oncology
urology
TOPIC
Systemic Treatments of Metastatic Prostate Cancer.
VISION
Patients having the best treatment option for metastatic prostate cancer.
MISSION
Finding the drug that significantly improves the quality of life of patients.
PROJECT TITLE 1
Investigating the efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: Systematic Review and Meta-analysis.
PROJECT TITLE 2
Investigating the efficacy and safety of abiraterone, apalutamide and enzalutamide in metastatic hormone-sensitive prostate cancer: Systematic Review and Meta-analysis.
Publications
- Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies - IF: 4.000, Quality: Q1, Journal: Target Oncol
- Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC - IF: 4.100, Quality: D1, Journal: BJU Int